Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Immunoglobulin Light-chain Amyloidosis × Registries × Plasma cell × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Immunoglobulin Light-chain Amyloidosis 1

Interventions

Dexamethasone 43 Melphalan 27 Bortezomib 23 Cyclophosphamide 21 Filgrastim 16 Peripheral Blood Stem Cell Transplantation 15 Calcium Dobesilate 14 daratumumab 11 pomalidomide 9 Lenalidomide 8 fludarabine phosphate 6 dexamethasone acetate 6 Whole-Body Irradiation 5 Thalidomide 5 Mycophenolic Acid 5 Granulocyte Colony-Stimulating Factor 5 Cyclosporine 5 venetoclax 4 ixazomib 4 dexamethasone 21-phosphate 4 birtamimab 4 Busulfan 4 miridesap 3 belantamab mafodotin 3 auricularum 3 Specimen Handling 3 Radiotherapy 3 Interferon-alpha 3 Focal Adhesion Protein-Tyrosine Kinases 3 Etoposide 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05174338 2023-09-06

CARS

Cedars-Sinai Medical Center

Immunoglobulin Light-chain Amyloidosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡